View Document Preview and Link Document Date: 1998-05-27 11:51:59 Open Document File Size: 299,59 KB Share Result on Facebook
Company Merck Research Laboratories / / Country United States / / Event FDA Phase / Reorganization / / Facility Parklawn Building / DR. TEMPLE / Bob Temple / / IndustryTerm treatment for this syndrome / / MedicalCondition additional unstable angina / refractory angina / hypertension / chest pain / disease / non-QA myocardial infarctions / plaque injury / non-Q-wave myocardial infarction / unstable angina MI / millimeter ST depression / pain / unstable angina pectoris / myocardial infarction / unstable angina / heart attack / coronary artery disease / unstable angina non-Q-wave infarction / Angina / myocardial infarctions / coronary heart disease / thrombus / MS / thrombosis / hypercholesterolemia / syndrome / subsequent thrombosis / / MedicalTreatment PTCA / bypass surgery / coronary artery bypass surgery / angioplasty / catheterization / concomitant therapy / atherectomy / pharmacotherapy / / Organization FDA / PRISM committee / Information Office / Center for Drug Evaluation and Research / Advisory Committee / Cardiovascular and Renal Drugs Advisory Committee / / Person Lemuel Moye / Lipicky / White / Marv Konstam / Robert Califf / Milton Packer / Dan Roden / Lem Moye / Rick Sax / Thadani / Cindy Grines / Borer / Marvin Konstam / Larry Bell / Snapinn / / Position investigator / cardiologist / leader / Chairman / physician / straight-forward / sub-investigator / / Product Aggrastat / mk3 / Tirofiban / / ProvinceOrState Michigan / / SocialTag 
